Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1981 1
1984 1
1985 2
1986 1
1989 3
1990 2
1991 1
1994 1
1995 1
1996 1
2001 2
2003 1
2004 1
2005 2
2008 2
2009 2
2010 2
2011 4
2012 3
2013 4
2014 3
2015 3
2016 1
2018 2
2019 1
2020 4
2021 2
2023 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype.
Micol R, Ben Slama L, Suarez F, Le Mignot L, Beauté J, Mahlaoui N, Dubois d'Enghien C, Laugé A, Hall J, Couturier J, Vallée L, Delobel B, Rivier F, Nguyen K, Billette de Villemeur T, Stephan JL, Bordigoni P, Bertrand Y, Aladjidi N, Pedespan JM, Thomas C, Pellier I, Koenig M, Hermine O, Picard C, Moshous D, Neven B, Lanternier F, Blanche S, Tardieu M, Debré M, Fischer A, Stoppa-Lyonnet D; CEREDIH Network Investigators. Micol R, et al. J Allergy Clin Immunol. 2011 Aug;128(2):382-9.e1. doi: 10.1016/j.jaci.2011.03.052. Epub 2011 Jun 12. J Allergy Clin Immunol. 2011. PMID: 21665257
Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis.
Ruperto N, Brunner HI, Quartier P, Constantin T, Wulffraat N, Horneff G, Brik R, McCann L, Kasapcopur O, Rutkowska-Sak L, Schneider R, Berkun Y, Calvo I, Erguven M, Goffin L, Hofer M, Kallinich T, Oliveira SK, Uziel Y, Viola S, Nistala K, Wouters C, Cimaz R, Ferrandiz MA, Flato B, Gamir ML, Kone-Paut I, Grom A, Magnusson B, Ozen S, Sztajnbok F, Lheritier K, Abrams K, Kim D, Martini A, Lovell DJ; PRINTO; PRCSG. Ruperto N, et al. N Engl J Med. 2012 Dec 20;367(25):2396-406. doi: 10.1056/NEJMoa1205099. N Engl J Med. 2012. PMID: 23252526 Free article. Clinical Trial.
Toxicokinetics of paraquat in humans.
Houzé P, Baud FJ, Mouy R, Bismuth C, Bourdon R, Scherrmann JM. Houzé P, et al. Among authors: mouy r. Hum Exp Toxicol. 1990 Jan;9(1):5-12. doi: 10.1177/096032719000900103. Hum Exp Toxicol. 1990. PMID: 2328151
French protocol for the diagnosis and management of juvenile idiopathic arthritis including pediatric-onset Still's disease.
Quartier P, Belot A, Breton S, Carbasse A, Devauchelle V, Fautrel B, Georgin-Lavialle S, Jurquet AL, Koné-Paut I, Lemelle I, Meinzer U, Melki I, Pillet P, Reumaux H, Rossi-Semerano L, Uettwiller F; Collaborators. Quartier P, et al. Rev Med Interne. 2025 Aug;46(8):449-481. doi: 10.1016/j.revmed.2025.06.001. Epub 2025 Jun 20. Rev Med Interne. 2025. PMID: 40544011 Free article.
Targeting the chemokine receptor CXCR4 with histamine analog to reduce inflammation in juvenile arthritis.
Bekaddour N, Smith N, Beitz B, Llibre A, Dott T, Baudry A, Korganow AS, Nisole S, Mouy R, Breton S, Bader-Meunier B, Duffy D, Terrier B, Schneider B, Quartier P, Rodero MP, Herbeuval JP. Bekaddour N, et al. Among authors: mouy r. Front Immunol. 2023 Sep 26;14:1178172. doi: 10.3389/fimmu.2023.1178172. eCollection 2023. Front Immunol. 2023. PMID: 37822935 Free PMC article.
Interferon gamma for chronic granulomatous disease.
Mouy R, Seger R, Bourquin JP, Veber F, Blanche S, Griscelli C, Fischer A. Mouy R, et al. N Engl J Med. 1991 Nov 21;325(21):1516-7. doi: 10.1056/NEJM199111213252115. N Engl J Med. 1991. PMID: 1944433 Clinical Trial. No abstract available.
Chronic granulomatous disease: the European experience.
van den Berg JM, van Koppen E, Ahlin A, Belohradsky BH, Bernatowska E, Corbeel L, Español T, Fischer A, Kurenko-Deptuch M, Mouy R, Petropoulou T, Roesler J, Seger R, Stasia MJ, Valerius NH, Weening RS, Wolach B, Roos D, Kuijpers TW. van den Berg JM, et al. Among authors: mouy r. PLoS One. 2009;4(4):e5234. doi: 10.1371/journal.pone.0005234. Epub 2009 Apr 21. PLoS One. 2009. PMID: 19381301 Free PMC article.
French expert opinion for the management of juvenile dermatomyositis.
Bader-Meunier B, Gitiaux C, Belot A, Brochard K, Mouy R, Ponce D, Bughin V, Jouen F, Musset L, Allenbach Y, Hachulla E, Maillard H, Meyer A, Bourrat E, Benveniste O; French Network of rare autoimmune, autoinflammatory diseases FAI2R. Bader-Meunier B, et al. Among authors: mouy r. Arch Pediatr. 2019 Feb;26(2):120-125. doi: 10.1016/j.arcped.2018.12.002. Epub 2019 Jan 10. Arch Pediatr. 2019. PMID: 30638764
Leflunomide or methotrexate for juvenile rheumatoid arthritis.
Silverman E, Mouy R, Spiegel L, Jung LK, Saurenmann RK, Lahdenne P, Horneff G, Calvo I, Szer IS, Simpson K, Stewart JA, Strand V; Leflunomide in Juvenile Rheumatoid Arthritis (JRA) Investigator Group. Silverman E, et al. Among authors: mouy r. N Engl J Med. 2005 Apr 21;352(16):1655-66. doi: 10.1056/NEJMoa041810. N Engl J Med. 2005. PMID: 15843668 Free article. Clinical Trial.
53 results